The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Anti-inflammatory therapies for atherosclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citationInflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Self-citationThe immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Self-citationBevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Phospholipase A2 structure/function, mechanism, and signaling
Burke, J. E., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800033-jlr200 · Cited by 933
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Topol, E., Califf, R., Weisman, H., Ellis, S., Tcheng, J., Worley, S., Ivanhoe, R., George, B., Fintel, D., Weston, M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90007-8 · Cited by 838
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Palinski, W., Miller, E., & Witztum, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.821 · Cited by 590
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
The STABILITY Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315878 · Cited by 579
George, J., Carr, E., Davies, J., Belch, J. J. F., & Struthers, A. (2006) · Circulation · doi:10.1161/circulationaha.106.651117 · Cited by 569
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Micha, R., Imamura, F., Wyler von Ballmoos, M., Solomon, D. H., Hernán, M. A., Ridker, P. M., & Mozaffarian, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.054 · Cited by 535
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
Libby, P., Warner, S. J., & Friedman, G. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113346 · Cited by 533
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Serruys, P. W., García-García, H. M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., Bøtker, H. E., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.771899 · Cited by 505
Biomechanical factors in atherosclerosis: mechanisms and clinical implications
Kwak, B. R., Bäck, M., Bochaton-Piallat, M.-L., Caligiuri, G., Daemen, M. J. A. P., Davies, P. F., Hoefer, I. E., Holvoet, P., Jo, H., Krams, R., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu353 · Cited by 502
Self-citationHas Our Understanding of Calcification in Human Coronary Atherosclerosis Progressed?
Otsuka, F., Sakakura, K., Yahagi, K., Joner, M., & Virmani, R. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302642 · Cited by 500
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
O’Donoghue, M. L., Braunwald, E., White, H. D., Steen, D. P., Lukas, M. A., Tarka, E., Steg, P. G., Hochman, J. S., Bode, C., Maggioni, A. P., et al. (2014) · JAMA · doi:10.1001/jama.2014.11061 · Cited by 456
Davenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Wållberg‐Jonsson, S., Ohman, M. L., & Dahlqvist, S. R. (1997) · PubMed · Cited by 417
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
Taylor, P. C., & Feldmann, M. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.181 · Cited by 389
Xu, Q., Dietrich, H., Steiner, H. J., Gown, A. M., Schoel, B., Mikuz, G., Kaufmann, S. H., & Wick, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.7.789 · Cited by 388
Wilensky, R. L., Shi, Y., Mohler, E. R., Hamamdzic, D., Burgert, M. E., Li, J., Postle, A., Fenning, R. S., Bollinger, J. G., Hoffman, B. E., et al. (2008) · Nature Medicine · doi:10.1038/nm.1870 · Cited by 387
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368
Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J. (2010) · Rheumatology · doi:10.1093/rheumatology/kep366 · Cited by 357
Ameli, S., Hultgårdh-Nilsson, A., Regnström, J., Calara, F., Yano, J., Cercek, B., Shah, P. K., & Nilsson, J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1074 · Cited by 355
Noman, A., Ang, D. S., Ogston, S., Lang, C. C., & Struthers, A. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60391-1 · Cited by 348
Nicholls, S. J., Kastelein, J. J. P., Schwartz, G. G., Bash, D., Rosenson, R. S., Cavender, M. A., Brennan, D. M., Koenig, W., Jukema, J. W., Nambi, V., et al. (2014) · JAMA · doi:10.1001/jama.2013.282836 · Cited by 344
Jonasson, L., Holm, J., Skalli, O., Gabbiani, G., & Hansson, G. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111934 · Cited by 311
Self-citationThe Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Kolodgie, F. D., Burke, A. P., Skorija, K. S., Ladich, E., Kutys, R., Makuria, A. T., & Virmani, R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000244681.72738.bc · Cited by 309
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Self-citationJudkins, C. P., Diep, H., Broughton, B. R. S., Mast, A. E., Hooker, E. U., Miller, A. A., Selemidis, S., Dusting, G. J., Sobey, C. G., & Drummond, G. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2009 · Cited by 299
LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis
Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. K., & Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.108 · Cited by 290
Self-citationRyan, C., Leonardi, C. L., Krueger, J. G., Kimball, A. B., Strober, B. E., Gordon, K. B., Langley, R. G., de Lemos, J. A., Daoud, Y., Blankenship, D., et al. (2011) · JAMA · doi:10.1001/jama.2011.1211 · Cited by 289
Coronary Stent Restenosis in Patients Treated With Cilostazol
Douglas, J. S., Holmes, D. R., Kereiakes, D. J., Grines, C. L., Block, E., Ghazzal, Z. M. B., Morris, D. C., Liberman, H., Parker, K., Jurkovitz, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.530097 · Cited by 281
Weber, C., Meiler, S., Döring, Y., Koch, M., Drechsler, M., Megens, R. T. A., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44925 · Cited by 273
Hansson, G. K., Hellstrand, M., Rymo, L., Rubbia, L., & Gabbiani, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1595 · Cited by 268
Self-citationGeorge, J., Afek, A., Gilburd, B., Levkovitz, H., Shaish, A., Goldberg, I., Kopolovic, Y., Wick, G., Shoenfeld, Y., & Harats, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00015-x · Cited by 267
Maron, R., Sukhova, G., Faria, A.-M., Hoffmann, E., Mach, F., Libby, P., & Weiner, H. L. (2002) · Circulation · doi:10.1161/01.cir.0000029750.99462.30 · Cited by 267
Biomechanical factors in the biology of aortic wall and aortic valve diseases
Bäck, M., Gasser, T. C., Michel, J.-B., & Caligiuri, G. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt040 · Cited by 263
Self-citationStatins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor
Parmar, K. M., Nambudiri, V., Dai, G., Larman, H. B., Gimbrone, M. A., & García-Cardeña, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500144200 · Cited by 253
Lutgens, E., Lievens, D., Beckers, L., Wijnands, E., Soehnlein, O., Zernecke, A., Seijkens, T., Engel, D., Cleutjens, J., Keller, A. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091293 · Cited by 246
Hakonarson, H., Thorvaldsson, S., Helgadottir, A., Gudbjartsson, D., Zink, F., Andresdottir, M., Manolescu, A., Arnar, D. O., Andersen, K., Sigurdsson, A., et al. (2005) · JAMA · doi:10.1001/jama.293.18.2245 · Cited by 236
Bäck, M., Bu, D.-X., Bränström, R., Sheikine, Y., Yan, Z.-Q., & Hansson, G. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505845102 · Cited by 230
Self-citationCRITTENDEN, D. B., LEHMANN, R. A., SCHNECK, L., KEENAN, R. T., SHAH, B., GREENBERG, J. D., CRONSTEIN, B. N., SEDLIS, S. P., & PILLINGER, M. H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111533 · Cited by 222
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12665 · Cited by 217
Self-citationBousser, M.-G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K. M., Hennerici, M. G., Mattle, H. P., Rothwell, P. M., de Cordoüe, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60600-4 · Cited by 216
Xu, Q., Kleindienst, R., Waitz, W., Dietrich, H., & Wick, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116508 · Cited by 206
Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., Ketelhuth, D. F. J., Gerdes, N., Holmgren, J., Nilsson, J., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202671 · Cited by 201
Self-citationColchicine: Its mechanism of action and efficacy in crystal-induced inflammation
Nuki, G. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0036-3 · Cited by 199
Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65
George, J., Shoenfeld, Y., Afek, A., Gilburd, B., Keren, P., Shaish, A., Kopolovic, J., Wick, G., & Harats, D. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.505 · Cited by 198
Gisterå, A., Robertson, A.-K. L., Andersson, J., Ketelhuth, D. F. J., Ovchinnikova, O., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006133 · Cited by 194
Self-citationGilbert, J., Lekstrom-Himes, J., Donaldson, D., Lee, Y., Hu, M., Xu, J., Wyant, T., & Davidson, M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.005 · Cited by 185
Ahlehoff, O., Skov, L., Gislason, G., Lindhardsen, J., Kristensen, S. L., Iversen, L., Lasthein, S., Gniadecki, R., Dam, T. N., Torp‐Pedersen, C., et al. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02593.x · Cited by 177
Tzellos, T., Kyrgidis, A., & Zouboulis, C. C. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04500.x · Cited by 173
Higgins, P., Dawson, J., Lees, K. R., McArthur, K., Quinn, T. J., & Walters, M. R. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00277.x · Cited by 164
Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis
van Puijvelde, G. H. M., Hauer, A. D., de Vos, P., van den Heuvel, R., van Herwijnen, M. J. C., van der Zee, R., van Eden, W., van Berkel, T. J. C., & Kuiper, J. (2006) · Circulation · doi:10.1161/circulationaha.106.615609 · Cited by 164
Newby, L. K., Marber, M. S., Melloni, C., Sarov‐Blat, L., Aberle, L. H., Aylward, P. E., Cai, G., de Winter, R. J., Hamm, C. W., Heitner, J. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60417-7 · Cited by 163
Role for Nox1 NADPH oxidase in atherosclerosis
Sheehan, A. L., Carrell, S., Johnson, B., Stanić, B., Bánfi, B., & Miller, F. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.028 · Cited by 162
Tardif, J., L’Allier, P. L., Ibrahim, R., Grégoire, J. C., Nozza, A., Cossette, M., Kouz, S., Lavoie, M.-A., Paquin, J., Brotz, T. M., et al. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.937169 · Cited by 161
Elkhawad, M., Rudd, J. H. F., Sarov‐Blat, L., Cai, G., Wells, R., Davies, C., Collier, D., Marber, M. S., Choudhury, R. P., Fayad, Z. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.016 · Cited by 158
Tsimikas, S., Tsironis, L. D., & Tselepis, A. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000280571.28102.d4 · Cited by 152
Phospholipase A2 enzymes and the risk of atherosclerosis
Rosenson, R. S., & Hurt‐Camejo, E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs148 · Cited by 147
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.
Jonasson, L., Holm, J., & Hansson, G. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2303 · Cited by 144
Self-citationHeller, E. A., Liu, E. H., Tager, A. M., Sinha, S., Roberts, J. D., Koehn, S. L., Libby, P., Aïkawa, E., Chen, J. Q., Huang, P. L., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.545616 · Cited by 143
Vanthienen, J., Fledderus, J. O., Dekker, R. J., Rohlena, J., VANIJZENDOORN, G., Kootstra, N. A., Pannekoek, H., & Horrevoets, A. J. G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.008 · Cited by 141
Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis
Rådmark, O., & Samuelsson, B. O. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.173 · Cited by 136
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
Chatzigeorgiou, A., Seijkens, T. T. P., Zarzycka, B. A., Engel, D. A., Poggi, M., van den Berg, S. M., van den Berg, S. A. A., Soehnlein, O., Winkels, H., Beckers, L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400419111 · Cited by 134
Iida, O., Yokoi, H., Soga, Y., Inoue, N., Suzuki, K., Yokoi, Y., Kawasaki, D., Zen, K., Urasawa, K., Shintani, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000711 · Cited by 132
Kushiyama, A., Okubo, H., Sakoda, H., Kikuchi, T., Fujishiro, M., Sato, H., Kushiyama, S., Iwashita, M., Nishimura, F., Fukushima, T., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234559 · Cited by 130
Ingelsson, E., Yin, L., & Bäck, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.052 · Cited by 126
Self-citationBäck, M., Sultan, A., Овчинникова, О. А., & Hansson, G. K. (2007) · Circulation Research · doi:10.1161/01.res.0000264498.60702.0d · Cited by 123
Self-citationNagy, E., Andersson, D. C., Caidahl, K., Eriksson, M. J., Eriksson, P. O., Franco‐Cereceda, A., Hansson, G. K., & Bäck, M. (2011) · Circulation · doi:10.1161/circulationaha.110.966846 · Cited by 117
Self-citationCapra, V., Bäck, M., Angiolillo, D. J., Cattaneo, M., & Sakaríassen, K. S. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12472 · Cited by 114
Self-citationDifferential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112
Impact of allopurinol on risk of myocardial infarction
Grimaldi‐Bensouda, L., Alpérovitch, A., Aubrun, E., Danchin, N., Rossignol, M., Abenhaim, L., & Richette, P. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202972 · Cited by 112
Leukotriene receptors in atherosclerosis
Bäck, M., & Hansson, G. K. (2006) · Annals of Medicine · doi:10.1080/07853890600982737 · Cited by 109
Self-citationPhosphodiesterase-4 Inhibitor Therapy for Lung Diseases
Beghé, B., Rabe, K. F., & Fabbri, L. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0021pp · Cited by 108
Ali, F., Zakkar, M., Karu, K., Lidington, E. A., Hamdulay, S., Boyle, J. J., Zloh, M., Bauer, A., Haskard, D. O., Evans, P. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009886 · Cited by 104
Jawień, J., Gajda, M., Rudling, M., Mateuszuk, Ł., Olszanecki, R., Guzik, T. J., Cichocki, T., Chłopicki, S., & Korbut, R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01606.x · Cited by 103
Cheriyan, J., Webb, A. J., Sarov‐Blat, L., Elkhawad, M., Wallace, S. M. L., Maki-Petaja, K. M., Collier, D., Morgan, J., Fang, Z., Willette, R. N., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.971986 · Cited by 102
Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
White, W. B., Cooke, G. E., Kowey, P. R., Calverley, P. M. A., Bredenbröker, D., Goehring, U.-M., Zhu, H., Lakkis, H. D., Mosberg, H., Rowe, P., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-2332 · Cited by 102
Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits
Bulgarelli, A., Dias, A. A. M., Caramelli, B., & Maranhão, R. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318241c385 · Cited by 101
Chemokines: established and novel targets in atherosclerosis
Koenen, R. R., & Weber, C. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100183 · Cited by 100
Shah, P. K., Chyu, K., Dimayuga, P. C., & Nilsson, J. Å. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.018 · Cited by 99
Morris, J. B., Olzinski, A. R., Bernard, R. E., Aravindhan, K., Mirabile, R. C., Boyce, R. W., Willette, R. N., & Jucker, B. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151175 · Cited by 95
Rosenson, R. S., Hislop, C., Elliott, M. D., Stasiv, Y., Goulder, M. A., & Waters, D. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.015 · Cited by 95
Bäck, M., Yin, L., & Ingelsson, E. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr421 · Cited by 92
Self-citationFraser, H. I., Hislop, C., Christie, R. M., Rick, H. L., Reidy, C. A., Chouinard, M. L., Eacho, P. I., Gould, K. E., & Trias, J. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318195bfbc · Cited by 88
Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
Fisk, M., Gajendragadkar, P. R., Maki-Petaja, K. M., Wilkinson, I. B., & Cheriyan, J. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0063-6 · Cited by 86
Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid Arteries
Stemme, V., Swedenborg, J., Claesson, H. E., & Hansson, G. K. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2000.1145 · Cited by 84
Self-citationAkifumiKushiyama, HirofumiOkubo, HideyukiSakoda, TakakoKikuchi, MidoriFujishiro, HirokazuSato, SakuraKushiyama, MisakiIwashita, FusanoriNishimura, ToshiakiFukushima, et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 79
Souness, J. E., Hassall, G. A., & Parrott, D. P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90116-z · Cited by 77
Ait‐Oufella, H., Herbin, O., Lahoute, C., Coatrieux, C., Loyer, X., Joffre, J., Laurans, L., Ramkhelawon, B., Blanc‐Brude, O., Karabina, S., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300309 · Cited by 77
Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery
Marks, A. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038141 · Cited by 72
Seeger, F. H., Sedding, D., Langheinrich, A. C., Haendeler, J., Zeiher, A. M., & Dimmeler, S. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0072-9 · Cited by 72
Secretory phospholipase A2: A multifaceted family of proatherogenic enzymes
Rosenson, R. S., & Gelb, M. H. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0064-2 · Cited by 70
Mueller, C. F. H., Wassmann, K., Widder, J. D., Waßmann, S., Chen, C. H., Keuler, B., Kudin, A. P., Kunz, W. S., & Nickenig, G. (2008) · Circulation · doi:10.1161/circulationaha.107.747667 · Cited by 69
Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis
Labat, C., Temmar, M., Nagy, E., Bean, K., Brink, C., Bénétos, A., & Bäck, M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328363dccc · Cited by 68
Self-citationSildenafil restores endothelial function in the apolipoprotein E knockout mouse
Balarini, C. M., Leal, M. A. S., Gomes, I. B., Pereira, T. M. C., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-3 · Cited by 68
Marco, E. D., Gray, S. P., Chew, P., Koulis, C., Ziegler, A. I., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., Slattery, R. M., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3118-3 · Cited by 66
Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
Bäck, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058020 · Cited by 66
Self-citationTargeted Deletions of Cyclooxygenase-2 and Atherogenesis in Mice
Hui, Y., Ricciotti, E., Crichton, I., Zhou, Y., Wang, D., Stubbe, J., Wang, M., Puré, E., & FitzGerald, G. A. (2010) · Circulation · doi:10.1161/circulationaha.109.910687 · Cited by 65
Tang, S. Y., Monslow, J., Todd, L., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2014) · Circulation · doi:10.1161/circulationaha.113.007913 · Cited by 64
Shaposhnik, Z., Wang, X., Trias, J., Fraser, H. I., & Lusis, A. J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800361-jlr200 · Cited by 64
Allayee, H., Hartiala, J., Lee, W., Mehrabian, M., Irvin, C. G., Conti, D. V., & Lima, J. J. (2007) · CHEST Journal · doi:10.1378/chest.07-0831 · Cited by 62
Rentoukas, E. I., Tsarouhas, K., Tsitsimpikou, C., Lazaros, G. A., Deftereos, S. G., & Vavetsi, S. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.08.037 · Cited by 58
NOD2-Mediated Innate Immune Signaling Regulates the Eicosanoids in Atherosclerosis
Liu, H., Zhang, X., Edfeldt, K., Nijhuis, M. M. O., Idborg, H., Bäck, M., Roy, J., Hedin, U., Jakobsson, P., Laman, J. D., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301715 · Cited by 56
Self-citationSarov‐Blat, L., Morgan, J. M., Fernandez, P., James, R., Fang, Z., Hurle, M. R., Baidoo, C. A., Willette, R. N., Lepore, J. J., Jensen, S. E., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209205 · Cited by 56
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion
Gabrielsen, A., Qiu, H., Bäck, M., Hámberg, M., Hemdahl, A.-L., Agardh, H. E., Folkersen, L., Swedenborg, J., Hedin, U., Paulsson‐Berne, G., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0621-6 · Cited by 55
Self-citationZhou, Y., Crichton, I., Tang, S. Y., Hui, Y., Ricciotti, E., Levin, M. D., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115313109 · Cited by 54
Hlawaty, H., Jacob, M., Louedec, L., Letourneur, D., Brink, C., Michel, J., Feldman, L. J., & Bäck, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181750 · Cited by 53
Self-citationColchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., & Thompson, P. L. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0391-z · Cited by 42
Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea
Stanke‐Labesque, F., Pépin, J., de Jouvencel, T., Arnaud, C., Baguet, J.-P., Petri, M. H., Tamisier, R., Jourdil, J., Levy, P. A., & Bäck, M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022814 · Cited by 40
Self-citationBabaev, V. R., Ding, L., Reese, J., Morrow, J. D., Breyer, M. D., Dey, S. K., Fazio, S., & Linton, M. F. (2005) · Circulation · doi:10.1161/circulationaha.105.591537 · Cited by 39
Measles Virus Nucleoprotein Induces a Regulatory Immune Response and Reduces Atherosclerosis in Mice
Ait‐Oufella, H., Horvat, B., Kerdiles, Y. M., Herbin, O., Gourdy, P., Khallou‐Laschet, J., Merval, R., Esposito, B., Tedgui, A., & Mallat, Z. (2007) · Circulation · doi:10.1161/circulationaha.107.699470 · Cited by 37
Interleukin-12 Is Associated With Arterial Stiffness in Healthy Individuals
Yong, K., Dogra, G. K., Boudville, N. C., Chan, D. T., Adams, L. A., Ching, H., Lim, E. M., & Lim, W. H. (2012) · American Journal of Hypertension · doi:10.1093/ajh/hps032 · Cited by 36
T Cell-based Therapies for Atherosclerosis
Ketelhuth, D. F. J., Gisterå, A., Johansson, D. K., & Hansson, G. K. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319330003 · Cited by 34
Self-citationEvidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques
Bitto, A., Caridi, G. D., Polito, F., Calò, M., Irrera, N., Altavilla, D., Spinelli, F., & Squadrito, F. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.05.116 · Cited by 34
Petri, M. H., Tellier, C., Michiels, C., Ellertsen, I., Dogné, J., & Bäck, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.078 · Cited by 28
Self-citationInterleukin-23 serum levels in patients affected by peripheral arterial disease
David, A., Saitta, S., Caridi, G. D., Benedetto, F., Massara, M., Risitano, D. C., Venuti, F. S., Spinelli, F., & Gangemi, S. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.12.010 · Cited by 18
Caterina, R. D., Giannessi, D., Lazzerini, G., Bernini, W., Sicari, R., Cupelli, F., Lenzi, S. M., Rugolotto, M., Madonna, R., & Maclouf, J. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02261.x · Cited by 12
Could Direct Inhibition of Inflammation Be the “Next Big Thing” in Treating Atherosclerosis?
Natarajan, P., & Cannon, C. P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213793 · Cited by 10
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Self-citationNLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Clinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E. L., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 909
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 815
Metadata
- Authors
- Bäck, M., & Hansson, G. K.
- Venue
- Nature Reviews Cardiology
- Published
- 2015-02-10
- Volume
- 12
- Issue
- 4
- Pages
- 199-211
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2035192731
- Cited by
- 378
- References
- 140
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.